Friday February 24th 2017: Sanofi, SNY is in the exchange NYSE and its industry is Drug Manufacturers – Major in the sector of Healthcare. Based in France, Sanofi, SNY has a market cap of 120.86 B. Since its IPO date on the 07/01/2002, Sanofi, SNY performance year to date is 18.03%. Today Sanofi, SNY has gained -0.08%, with a current price of 47.73.
Ownership of the company is 16.40% for insider ownership while institutional ownership is 10.60%. The management of the company have seen the company have a payout ratio of 38.30%. Return of assets are at *TBA, with return on investment at 6.20%.
In terms of debt levels and profit levels, Sanofi, SNY is seeing a long-term debt/equity of *TBA. While Total debt/equity is *TBA. With a profit margin of 27.60%, this is combined with a gross margin of 69.10%, and operating margin of 21.20%. Sanofi ability to meet debt levels, with a current ratio of *TBA, while the quick ratio is *TBA.
For the last year Sanofi, SNY has seen a EPS growth of 1.40%. A performance for the year of 24.30%. The 52-week high is -5.00%, and the 52-week low is 29.67%. The average volume for Sanofi, SNY is 1511331.
With a target price of 51.75, can Sanofi, SNY reach this target? Looking at the value indicators of Sanofi, SNY. Sanofi has a P/E of 23.57 and a forward P/E of 14.21. Perhaps the more useful indicator than P/E, is PEG which has a value of 2.41. Sanofi also has a P/S and a P/B of 3.04 and 1.9 respectively. For P/cash, Sanofi has a value of *TBA, while it is *TBA for P/free cash flow.
At the current price of 47.73, Sanofi has a dividend yield of 3.44%. We see a return on equity of *TBA.
Looking more long-term Sanofi, is projected to get an EPS growth for the next five years of 9.80%. In the short-term an EPS growth of 6.77% in the next year is forecasted. This is after a EPS growth of 1.40% for this year and for the last five years a -4.60% growth has been seen.